Chemical, biological, radiological and nuclear (CBRN) cluster
In 2019 and 2020 the Commission will select several RIAs aiming at research and development of novel CBRN technologies and innovations identified in the catalogue that is updated by the ENCIRCLE project on a regular basis. Each of these actions will be led by an SME. Each consortium implementing such a RIA must not only establish a consortium agreement among its members, but also an agreement with the participants in the ENCIRCLE project which must settle how the results from the RIA will be exploited and integrated into platforms managed by ENCIRCLE.
Where applicable, the complementarity of the proposed activities with activities supported by the European Defence Agency (EDA) should be described comprehensively.
The centre of gravity for technology development with actions funded under this topic is expected to be up to TRL 4 to 6 – see General Annex G of the Horizon 2020 Work Programme.
Indicative budget: The Commission considers that proposals requesting a contribution from the EU of about EUR 3.5 million per action for this topic to be addressed appropriately. Nonetheless this does not preclude submission and selection of proposals requesting other amounts.
The following options of the Model Grant Agreement will be implemented:
- Option 1 of Article 41.3 of the Model Grant Agreement will be applied.
- Grants awarded under this topic will be complementary to the grant agreement under SEC-05-DRS-05-2016-2017 part a). The respective options of Article 2, Article 31.6 and Article 41.4 of the Model Grant Agreement[[http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/amga/h2020-amga_en.pdf]] will be applied.
Technologies and innovations in the field of CBRN are developed by companies which often face difficulties in bringing them to markets. At least three reasons may be identified:
- they address local, small niche markets;
- these companies have neither the capabilities nor the strategic objective to go for foreign markets;
- the individual technologies that they develop can make it to the market only if integrated and combined with other tools by other companies that have the capabilities and the strategy to market products abroad, and possibly on the global market.
In this context a platform has been established further to the response to topic SEC-05-DRS-2016-2017 in 2017. A larger number of innovative technologies, devices and services need to be added to this platform.
- Shorter time to market for novel CBRN technologies and innovations
- More business deals leading to industrial products of interest to more practitioners in Europe (and world-wide).